Key terms
About CYTO
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CYTO news
Yesterday
10:47am ET
Biotech Alert: Searches spiking for these stocks today
Mar 25
9:02am ET
Altamira Therapeutics enters collaboration with Univercells
Feb 07
8:48am ET
Altamira Therapeutics announces publication on peptide-based delivery platform
Jan 26
11:25am ET
Biotech Alert: Searches spiking for these stocks today
Jan 24
8:50am ET
Altamira Therapeutics files second provisional patent application for OligoPhore
Jan 08
5:05pm ET
Altamira Therapeutics files to sell 162,548 shares of common stock
Dec 29
8:48am ET
Altamira Therapeutics regains compliance with Nasdaq minimum bid price rule
No recent news articles are available for CYTO
No recent press releases are available for CYTO
CYTO Financials
Key terms
Ad Feedback
CYTO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CYTO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range